Halozyme Therapeutics (HALO) Receivables (2010 - 2026)
Halozyme Therapeutics (HALO) posted Receivables of $455.83 million for Q2 2026, up 44.1% from $316.34 million a year earlier but down 0.5% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics' Receivables came in at $441.27 million, up 34.2% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of 33.3% (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Receivables was $328.76 million in FY2024 (+39.8%), $235.21 million in FY2023 (-14.5%), $275.17 million in FY2022 (+202.5%) and $90.98 million in FY2021 (-13.1%).
- Quarterly Receivables has run from a low of $90.98 million in Q4 2021 to a high of $457.99 million in Q1 2026 over five years.
- On a year-over-year basis, Receivables has increased in each of the last eight quarters, with growth averaging 40.3% over the last eight quarters.
- The strongest year-over-year quarter for Receivables in the past five years was Q3 2022, with growth of 169.9%; the weakest was Q3 2023, with a decline of 27.1%.
- According to Business Quant data, Receivables for the three prior quarters was $457.99 million (Q1 2026), $441.27 million (Q4 2025) and $346.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 455.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 455.83 Mn |
| Mar 31, 2026 | 457.99 Mn |
| Dec 31, 2025 | 441.27 Mn |
| Sep 30, 2025 | 346.04 Mn |
| Jun 30, 2025 | 316.34 Mn |
| Mar 31, 2025 | 304.62 Mn |
| Dec 31, 2024 | 328.76 Mn |
| Sep 30, 2024 | 285.74 Mn |
| Jun 30, 2024 | 214.52 Mn |
| Mar 31, 2024 | 195.90 Mn |
| Dec 31, 2023 | 235.21 Mn |
| Sep 30, 2023 | 220.63 Mn |
| Jun 30, 2023 | 270.68 Mn |
| Mar 31, 2023 | 227.22 Mn |
| Dec 31, 2022 | 186.97 Mn |
| Sep 30, 2022 | 302.50 Mn |
| Jun 30, 2022 | 209.21 Mn |
| Mar 31, 2022 | 113.76 Mn |
| Dec 31, 2021 | 90.98 Mn |
| Sep 30, 2021 | 112.10 Mn |
API Access
Halozyme Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();